Dose-related effects of venlafaxine on pCREB and brain-derived neurotrophic factor (BDNF) in the hippocampus of the rat by chronic unpredictable stress

Acta Neuropsychiatrica

Volumn 23, Issue 1, 2011, Pages 20-30

  Li, Jing Jing ^a   Yuan, Yong Gui ^a,b   Hou, Gang ^a   Zhang, Xiang Rong ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b SOUTHEAST UNIVERSITY   (China)

Author keywords

brain derived neurotrophic factor; chronic unpredictable stress; cyclic AMP response element binding protein; hippocampus; neurogenesis

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MESSENGER RNA; VENLAFAXINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MEGADOSE; EXPLORATORY BEHAVIOR; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LOW DRUG DOSE; MALE; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; OPEN FIELD TEST; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

EID: 78651244525     PISSN: 09242708     EISSN: 16015215     Source Type: Journal    
DOI: 10.1111/j.1601-5215.2010.00512.x     Document Type: Article

References (45)

1. Brown J, Cooper-Kuhn CM, Kempermann G, et al., Enriched environment and physical activity stimulate hippocampal but not olfactory bulb neurogenesis. Eur J Neurosci 2003; 17: 2042-2046.
2. Willner P., Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berl) 1997; 134: 319-329.
3. Willner P., The validity of animal models of depression. Psychopharmacology (Berl) 1984; 83: 1-16.
4. Willner P, Towell A, Sampson D, Sophokleous S, Muscat R., Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology (Berl) 1987; 93: 358-364.
5. Muscat R, Papp M, Willner P., Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline. Psychopharmacology (Berl) 1992; 109: 433-438.
6. Muscat R, Papp M, Willner P., Antidepressant-like effects of dopamine agonists in an animal model of depression. Biol Psychiatry 1992; 31: 937-946.
7. Bondi CO, Rodriguez G, Gould GG, Frazer A, Morilak DA., Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment. Neuropsychopharmacology 2008; 33: 320-331.
8. Duman RS., Pathophysiology of depression: the concept of synaptic plasticity. Eur Psychiatry 2002; 17 (Suppl. 3): 306-310.
9. Duman RS., Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med 2004; 5: 11-25.
10. Duman RS, Monteggia LM., A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006; 59: 1116-1127.
11. Lindsay RM, Wiegand SJ, Altar CA, DiStefano PS., Neurotrophic factors: from molecule to man. Trends Neurosci 1994; 17: 182-190.
12. Smith MA, Makino S, Kvetnansky R, Post RM., Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 1995; 15: 1768-1777.
13. Xu H, Steven Richardson J, Li XM., Dose-related effects of chronic antidepressants on neuroprotective proteins BDNF, Bcl-2 and Cu/Zn-SOD in rat hippocampus. Neuropsychopharmacology 2003; 28: 53-62.
14. Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS., Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 2002; 22: 3251-3261.
15. Shaywitz AJ, Greenberg ME., CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem 1999; 68: 821-861.
16. Nibuya M, Morinobu S, Duman RS., Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 1995; 15: 7539-7547.
17. Nibuya M, Nestler EJ, Duman RS., Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 1996; 16: 2365-2372.
18. Nakagawa S, Kim JE, Lee R, et al., Localization of phosphorylated cAMP response element-binding protein in immature neurons of adult hippocampus. J Neurosci 2002; 22: 9868-9876. (Pubitemid 35332871)
19. Rudolph RL., Achieving remission from depression with venlafaxine and venlafaxine extended release: a literature review of comparative studies with selective serotonin reuptake inhibitors. Acta Psychiatr Scand Suppl 2002; 415: 24-30.
20. Willner P, Muscat R, Papp M., Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci Biobehav Rev 1992; 16: 525-534.
21. Kennett GA, Dickinson SL, Curzon G., Enhancement of some 5-HT-dependent behavioural responses following repeated immobilization in rats. Brain Res 1985; 330: 253-263.
22. Katz RJ, Roth KA, Carroll BJ., Acute and chronic stress effects on open field activity in the rat: implications for a model of depression. Neurosci Biobehav Rev 1981; 5: 247-251.
23. Gur E, Dremencov E, Lerer B, Newman ME., Venlafaxine: acute and chronic effects on 5-hydroxytryptamine levels in rat brain in vivo. Eur J Pharmacol 1999; 372: 17-24.
24. Willner P., Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005; 52: 90-110.
25. Mao QQ, Xian YF, Ip SP, Tsai SH, Che CT., Long-term treatment with peony glycosides reverses chronic unpredictable mild stress-induced depressive-like behavior via increasing expression of neurotrophins in rat brain. Behav Brain Res 2010; 210: 171-177.
26. Larsen MH, Mikkelsen JD, Hay-Schmidt A, Sandi C., Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment. J Psychiatr Res 2010; 44: 808-816.
27. Radley JJ, Sisti HM, Hao J, et al., Chronic behavioral stress induces apical dendritic reorganization in pyramidal neurons of the medial prefrontal cortex. Neuroscience 2004; 125: 1-6.
28. Sheline YI, Gado MH, Kraemer HC., Untreated depression and hippocampal volume loss. Am J Psychiatry 2003; 160: 1516-1518.
29. Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW., Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A 1996; 93: 3908-3913.
30. Laifenfeld D, Karry R, Grauer E, Klein E, Ben-Shachar D., Antidepressants and prolonged stress in rats modulate CAM-L1, laminin, and pCREB, implicated in neuronal plasticity. Neurobiol Dis 2005; 20: 432-441.
31. Sairanen M, O'Leary OF, Knuuttila JE, Castren E., Chronic antidepressant treatment selectively increases expression of plasticity-related proteins in the hippocampus and medial prefrontal cortex of the rat. Neuroscience 2007; 144: 368-374.
32. Davis S, Vanhoutte P, Pages C, Caboche J, Laroche S., The MAPK/ERK cascade targets both Elk-1 and cAMP response element-binding protein to control long-term potentiation-dependent gene expression in the dentate gyrus in vivo. J Neurosci 2000; 20: 4563-4572.
33. Pham TA, Impey S, Storm DR, Stryker MP., CRE-mediated gene transcription in neocortical neuronal plasticity during the developmental critical period. Neuron 1999; 22: 63-72.
34. Taubenfeld SM, Wiig KA, Monti B, Dolan B, Pollonini G, Alberini CM., Fornix-dependent induction of hippocampal CCAAT enhancer-binding protein [beta] and [delta] co-localizes with phosphorylated cAMP response element-binding protein and accompanies long-term memory consolidation. J Neurosci 2001; 21: 84-91.
35. Viola H, Furman M, Izquierdo LA, et al., Phosphorylated cAMP response element-binding protein as a molecular marker of memory processing in rat hippocampus: effect of novelty. J Neurosci 2000; 20: RC112.
36. Warner-Schmidt JL, Duman RS., Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment. Hippocampus 2006; 16: 239-249.
37. Xu H, Chen Z, He J, et al., Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus. Hippocampus 2006; 16: 551-559.
38. Thome J, Sakai N, Shin K, et al., cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J Neurosci 2000; 20: 4030-4036.
39. Cremer H, Chazal G, Lledo PM, et al., PSA-NCAM: an important regulator of hippocampal plasticity. Int J Dev Neurosci 2000; 18: 213-220.
40. Li J, Yuan Y, Hou G, Zhang Z., Effects of chronic antidepressant venlafaxine on the expression of plasticity-related proteins mRNA in the hippocampus of the rat by chronic unpredictable stress. Chin J Psychiatry 2008; 41: 102-106
41. Sairanen M, Lucas G, Ernfors P, Castren M, Castren E., Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. J Neurosci 2005; 25: 1089-1094.
42. Altar CA, Whitehead RE, Chen R, Wortwein G, Madsen TM., Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Biol Psychiatry 2003; 54: 703-709.
43. Dias BG, Banerjee SB, Duman RS, Vaidya VA., Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain. Neuropharmacology 2003; 45: 553-563.
44. Coppell AL, Pei Q, Zetterstrom TS., Bi-phasic change in BDNF gene expression following antidepressant drug treatment. Neuropharmacology 2003; 44: 903-910. (Pubitemid 36515026)
45. De Foubert G, Carney SL, Robinson CS, et al., Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment. Neuroscience 2004; 128: 597-604.